Medivation has run hard, and one big investor apparently thinks
that it's just getting started.
optionMONSTER's Heat Seeker monitoring system detected a surge of
unusual activity in the drug developer, which is already up 25
percent in the last month. Blocks of 1,000 February 65 calls and
2,500 February 70 calls were sold for $12.65 and $8.75
respectively. Volume was below the previous open interest in both
strikes, so it appears that existing positions were closed.
Around the same time, the trader
5,500 February 77.50 calls for $4.90 and sold an equal number of
February 90 calls for $0.90. He or she also sold 2,500 February 70
puts for $2.55. All three of those trades surpassed previous open
interest, indicating that new positions were initiated.
The investor was apparently sitting on huge profits in the 65s and
70s after MDVN's recent run. Exiting those positions freed up
capital, some of which was spent on a complex bullish trade in the
other three strikes.
Making the adjustment brought in a net $1.89 million, and the
trader now stands to collect an additional $6.875 million if the
shares close at $90 or higher at expiration in five weeks. There's
also downside risk because of the
. (See our
MDVN is down 1.21 percent to $76.22 in afternoon trading and has
been on a tear since getting flagged on our proprietary
webinar on Oct. 22. It initially bounced from its 200-day moving
average and reported strong earnings on Nov. 12 thanks to sales of
its XTANDI drug.
The shares then consolidated at record levels and slowly worked
higher before exploding off their 50-day moving average early this
month. Based on today's activity, at least one big investor is
betting that considerable upside remains in the next five weeks.
Management hasn't yet announced the date of its next earnings
release, but last year's calendar suggests that it will occur
before expiration in mid-February.
Total option volume is 12 times greater than average so far today,
according to the Heat Seeker.
I own MDVN shares.
Copyright © 2010 OptionMonster® Holdings, Inc. All Rights Reserved.